Clinical trial · Observational
Sarcopenia in Head and Neck Cancer Patients Treated with Curative Hadrontherapy
Role of Baseline Sarcopenia in Determining Acute Toxicity for Head and Neck Cancer Patients Treated with Curative Hadrontherapy: a Prospective Monoinstitutional Study
NCT06207708CI-TRIAL-00085913completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study focuses on the impact of sarcopenia on acute and late toxicities in head and neck tumor affected patients treated with particle therapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood biomarkers | Diagnostic Test | — | UNRESOLVED |
| questionnaires QLQ-FA12, Mini Nutritional Assessment Short Form, Nutritional Risk Screening, diet questionnaire of frequency, ,body mass index measurement | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- skeletal muscle strength mass (SMM)
- timeFrame
- before starting hadrontherapy treatment
- description
- measurement of sarcopenia to evaluate the development of the affection
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All HNC histologies and stages * Histological and/or radiological diagnosis of head and neck tumors * The patient is able to give consent * Definitive/postoperative treatment with curative intent * Age \>18 years * KPS\> 80 Exclusion Criteria: * Plurimetastiatic disease * Palliative intent and re-irradiation treatments * Known cases of any psychiatric and neurological diseases leading to disability (eg, manic disorder, schizophrenia etc..), which could impair compilation of questionnaires
References
Publications (0)
Data not yet available
No reference posted for this study.